Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals
South China Morning Post
by Julie ZhangMarch 1, 2026
Chinese pharmaceutical firms are poised for profit growth, driven by innovative drug sales and licensing deals, despite pricing pressures.
Verticals
worldasia
Originally published on South China Morning Post on 3/1/2026